162 research outputs found
The Epsilon Calculus and Herbrand Complexity
Hilbert's epsilon-calculus is based on an extension of the language of
predicate logic by a term-forming operator . Two fundamental
results about the epsilon-calculus, the first and second epsilon theorem, play
a role similar to that which the cut-elimination theorem plays in sequent
calculus. In particular, Herbrand's Theorem is a consequence of the epsilon
theorems. The paper investigates the epsilon theorems and the complexity of the
elimination procedure underlying their proof, as well as the length of Herbrand
disjunctions of existential theorems obtained by this elimination procedure.Comment: 23 p
Military Resource Allocation as a Set Covering Problem
Fixed location resource allocation modeled as a set covering problem is a classic integer program. This framework has been widely applied to emergency service resource allocation, and this paper extends this approach to military resource allocation. Using military air medical evacuation resource allocation in Afghanistan as a proof of concept, a methodology is presented that could easily extend to other operational environments and other military resource allocation problems. Unique contributions include clustering of enemy activity reports to support demand signal analysis and consideration of set covering requirements for varying demand signal density
A dual investigation of the effect of dietary supplementation with licorice flavonoid oil on anthropometric and biochemical markers of health and adiposity
<p>Abstract</p> <p>Background</p> <p>Licorice flavonoid oil (LFO) has been reported to minimize visceral adipose tissue gain in obese mice and to result in a decrease in body weight and body fat in humans; the effects of which may be more pronounced when administered in an overfed state.</p> <p>Methods</p> <p>We investigated the effects of LFO in two separate studies. Study 1 included a sample of overweight or grade I-II obese men and women (N = 22) who followed their usual dietary and physical activity programs. Study 2 included a sample of athletic men who followed their usual dietary and physical activity programs but consumed a daily supplemental meal (25% above daily energy requirements) in an attempt to induce a state of overfeeding. In both studies, subjects were randomly assigned (double-blind) to either LFO or a placebo for eight weeks, and anthropometric and multiple biochemical outcomes (e.g., markers of oxidative stress, markers of insulin sensitivity, blood lipids, etc.) were obtained before and following the intervention.</p> <p>Results</p> <p>No differences of statistical significance were noted between LFO and placebo for any measured variable in Study 1 or Study 2. When investigating the percent change from baseline for data in Study 2, although not of statistical significance, subjects in the LFO condition experienced less overall fat gain, as well as attenuation in the elevation in selected blood lipids (e.g., cholesterol, LDL-C, and triglycerides).</p> <p>Conclusion</p> <p>These combined data indicate little effect of LFO supplementation within a sample of overweight/obese men and women or athletic men, with the possible exception of attenuation in body fat gain and selected components of the blood lipid panel in response to an overfeeding condition.</p
The Lunar Polar Hydrogen Mapper (LunaH-Map) CubeSat Mission
The Lunar Polar Hydrogen Mapper (LunaH-Map) is a 6U CubeSat mission recently selected by NASA\u27s Science Mission Directorate to fly as a secondary payload on first Exploration Mission (EM-1) of the Space Launch System (SLS), scheduled to launch in July 2018. LunaH-Map is led by a small team of researchers and students at Arizona State University, in collaboration with NASA centers, JPL, universities, and commercial space businesses. The LunaH-Map mission will reveal hydrogen abundances at spatial scales below 10 km in order to understand the relationship between hydrogen and permanently shadowed regions, particularly craters, at the Moon\u27s South Pole. The mission\u27s primary payload is designed to use the scintillator material Cs2YLiCl6:Ce, or CLYC to measure count rates of thermal and epithermal neutrons. Enabled by a low-thrust ion propulsion system, LunaH-Map will achieve lunar orbit insertion within ~12 months of SLS separation and maneuver into a highly elliptical, low-perilune (5-10 km) orbit centered around the South Pole of the Moon. In this orbit, LunaH-Map will achieve over 140 low-altitude fly-bys of the South Pole during its two month science phase. LunaH-Map and two fellow secondary payloads selected by NASA to fly on SLS EM-1 will be the first CubeSats to explore the Moon and interplanetary space
The ``Outside-In'' Outburst of HT Cassiopeiae
We present results from photometric observations of the dwarf nova system HT
Cas during the eruption of November 1995. The data include the first
two--colour observations of an eclipse on the rise to outburst. They show that
during the rise to outburst the disc deviates significantly from steady state
models, but the inclusion of an inner-disc truncation radius of about 4
and a ``flared'' disc of semi-opening angle of produces
acceptable fits. The disc is found to have expanded at the start of the
outburst to about , as compared to quiescent measurements. The
accretion disc then gradually decreases in radius reaching during
the last stages of the eruption. Quiescent eclipses were also observed prior to
and after the eruption and a revised ephemeris is calculated.Comment: 9 pages, 11 figures, to appear in MNRA
Decarbonising and Diversifying Defence in the US and the UK: A Workers’ Enquiry for a Just Transition: Full Report
Introduction: p.4
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors across 33 different cancer types. TCGA clinical data contain key features representing the democratized nature of the data collection process. To ensure proper use of this large clinical dataset associated with genomic features, we developed a standardized dataset named the TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR), which includes four major clinical outcome endpoints. In addition to detailing major challenges and statistical limitations encountered during the effort of integrating the acquired clinical data, we present a summary that includes endpoint usage recommendations for each cancer type. These TCGA-CDR findings appear to be consistent with cancer genomics studies independent of the TCGA effort and provide opportunities for investigating cancer biology using clinical correlates at an unprecedented scale. Analysis of clinicopathologic annotations for over 11,000 cancer patients in the TCGA program leads to the generation of TCGA Clinical Data Resource, which provides recommendations of clinical outcome endpoint usage for 33 cancer types
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context
Long noncoding RNAs (lncRNAs) are commonly dys-regulated in tumors, but only a handful are known toplay pathophysiological roles in cancer. We inferredlncRNAs that dysregulate cancer pathways, onco-genes, and tumor suppressors (cancer genes) bymodeling their effects on the activity of transcriptionfactors, RNA-binding proteins, and microRNAs in5,185 TCGA tumors and 1,019 ENCODE assays.Our predictions included hundreds of candidateonco- and tumor-suppressor lncRNAs (cancerlncRNAs) whose somatic alterations account for thedysregulation of dozens of cancer genes and path-ways in each of 14 tumor contexts. To demonstrateproof of concept, we showed that perturbations tar-geting OIP5-AS1 (an inferred tumor suppressor) andTUG1 and WT1-AS (inferred onco-lncRNAs) dysre-gulated cancer genes and altered proliferation ofbreast and gynecologic cancer cells. Our analysis in-dicates that, although most lncRNAs are dysregu-lated in a tumor-specific manner, some, includingOIP5-AS1, TUG1, NEAT1, MEG3, and TSIX, synergis-tically dysregulate cancer pathways in multiple tumorcontexts
- …